Gabelli Funds’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Gabelli Funds’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-130,000	Closed	-$5.36M	–	1121
2015 Q2	$5.36M	Sell	130,000 -7,000	-5%	-$251K	0.03%	566
2015 Q1	$4.83M	Sell	137,000 -2,200	-2%	-$74.4K	0.02%	593
2014 Q4	$4.47M	Hold	139,200	–	–	0.02%	619
2014 Q3	$3.91M	Buy	139,200 +48,700	+54%	+$1.48M	0.02%	646
2014 Q2	$2.73M	Hold	90,500	–	–	0.01%	726
2014 Q1	$2.5M	Hold	90,500	–	–	0.01%	727
2013 Q4	$2.31M	Sell	90,500 -700	-0.8%	-$21.6K	0.01%	731
2013 Q3	$2.73M	Hold	91,200	–	–	0.02%	683
2013 Q2	$2.62M	Buy	+91,200	New	+$2.51M	0.02%	661

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Gabelli Funds's BRLI Position: Q3 2015 in Review

Gabelli Funds sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 130,000 shares — an estimated $5.36M sold.

Gabelli Funds first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $5.36M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Gabelli Funds reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Gabelli Funds sold 130,000 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $5.36M.
Gabelli Funds first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Gabelli Funds's BIO-REFERENCE LABS INC-NEW- position peaked at $5.36M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Gabelli Funds's 13F filing for Q3 2015, filed 23 Oct 2015.